| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.05 |